BRITISH JOURNAL OF SURGERY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2021-12-27 衣谷

如何让审稿人读完摘要就可以了解我的研究？

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2021-08-13 145db63cm51暂无昵称

投稿

66 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2021-03-09 Lee7107

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：外科;手术
经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2020-02-09 走着瞧先森

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见

186 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2020-01-28 pk1990

有审稿意见吗adsci 2014-09-07 13:11:00 发表:
投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了

adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了

137 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

这个命中率高不

177 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2019-08-25 ms1998622456564216

审稿速度:1.0
经验分享：2019年08月19日投稿，20日under review

110 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2019-06-28 yx6808

Submited in June 4th, bless

164 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2019-04-23 ms8743830992601654

审稿速度:1.0
经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味

104 0

[GetPortalCommentsPageByObjectIdResponse(id=1088253, encodeId=06601088253bc, content=如何让审稿人读完摘要就可以了解我的研究？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007582, encodeId=205b100e582d9, content=投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b34e5093711, createdName=145db63cm51暂无昵称, createdTime=Fri Aug 13 13:16:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=946930, encodeId=99b09469309d, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：外科;手术 经验分享：感觉这个杂志对新的直肠癌术式并不是很认可，审稿一个半月。拒稿，两个审稿人的意见还可以，提了一些有用的意见。像是在编辑这里被拒掉的。大家加油, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEJjNrmHCssHruUnURNQ9DibvMdL9TVYcUwGtF6KnPl0vy3Qwzn0aibRiciaAf0WlFfXMNWaAvflbzVU7g/132, createdBy=a7b75291748, createdName=Lee7107, createdTime=Tue Mar 09 21:46:42 CST 2021, time=2021-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584440, encodeId=d9ab58444092, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投了以前综述，5天时间直接reject，没有送外审，稍微提了几个意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22805101721, createdName=走着瞧先森, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583930, encodeId=9bae58393039, content=有审稿意见吗adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, beContent=adsci 2014-09-07 13:11:00 发表: 投了一篇meta关于胰十二指肠切除术微创与开腹对比研究，一个月后拒稿，后来半个月后我在网上看到一个老外在已经接受了，当时还下载不下来，过了几个月我下下来一看，纳入的文章数还没我的多呢，可以人家已经annals of surgical oncology发表了，我这篇meta估计烂在手里了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUKFnnicyDWeJDeCqTGJ4iaOFJ3jUpiaYFPicTN8M1MoqDhHu8ETn3gDwTapnPMoVt7krm6wB3REVs4w/132, createdBy=f8265119733, createdName=pk1990, createdTime=Tue Jan 28 00:00:00 CST 2020, time=2020-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578548, encodeId=5be15e854865, content=这个命中率高不, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=853389, encodeId=3be78533895c, content=审稿速度:1.0 经验分享：2019年08月19日投稿，20日under review , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1355413958, createdName=ms1998622456564216, createdTime=Sun Aug 25 19:17:20 CST 2019, time=2019-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573050, encodeId=97ef5e3050dc, content=Submited in June 4th, bless, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ee383938, createdName=yx6808, createdTime=Fri Jun 28 10:20:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850994, encodeId=4df685099460, content=审稿速度:1.0 经验分享：回顾性研究，料想到被拒，刚好1个月时间收到消息，审稿人没有提出太多意见，可能还是不符合杂志口味 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14565413965, createdName=ms8743830992601654, createdTime=Tue Apr 23 22:45:20 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849150, encodeId=568784915047, content=外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a595414065, createdName=ms6437770273944149, createdTime=Wed Jan 09 17:43:18 CST 2019, time=2019-01-09, status=1, ipAttribution=)]

2019-01-09 ms6437770273944149

外科top期刊，虽然今年降了不少，仍然是非常好的期刊，拒稿率相当高，希望这次可以中

0 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务